Sparrow Quantum A/S is a privately held company that develops and commercializes photonic quantum technology components based on research and patents developed in the Niels Bohr Institute Quantum Photonics Lab. The Niels Bohr Institute’s Quantum Photonics Lab, headed by professor Peter Lodahl, is part of the Danish Center for Quantum Innovation, Qubiz, funded by Innovation Fund Denmark –– a national large scale investment in quantum technologies.
Arthex Biotech S.L. is a biotechnology company based in Paterna, Spain, that specializes in the development of antisense RNA therapies for genetic diseases. Founded in 2019 as a spin-off from the University of Valencia, the company focuses on addressing unmet medical needs through innovative treatments targeting microRNAs, which are implicated in various disorders, including neuromuscular diseases. With a team experienced in drug discovery and strong support from leading scientific and clinical advisors, Arthex Biotech aims to provide effective therapies for patients suffering from rare and challenging conditions.
nyris GmbH develops a visual product search platform. It serves companies across retail and e-commerce, industrial and manufacturing, media and entertainment, and financial services. The company was incorporated in 2015 and is based in Berlin, Germany with additional location in Dusseldorf.
Sensius B.V., founded in 2015 and based in Rotterdam, Netherlands, specializes in innovative cancer treatment through deep thermotherapy specifically targeting the head and neck region. As an Erasmus MC spinoff, the company focuses on developing novel hyperthermia techniques to enhance cancer care, providing a promising approach to improve treatment outcomes for patients suffering from tumors in these areas.
Developer of an automated disassembly and diagnostics solutions to maximize the value of every Li-ion battery. The company's proprietary computer vision models and robotic systems allow the autonomous handling of batteries of all variations, its disassembly process preserves material value and help companies to capture significant upcycling potential for cells and components, disassembly is entirely manual owing to wide variety in battery designs and changing conditions. enabling customers save significant cost, see positive carbon impacts vs recycling and find a solution to increasing labor shortage.
SILEANE specialists of robotics and vision.
ATXA Therapeutics Limited is a pharmaceutical company based in Dublin, Ireland, focused on developing novel small molecule drugs for the treatment of pulmonary arterial hypertension (PAH). Established in 2015 as a spin-out from University College Dublin, the company has leveraged over 20 years of research and more than €15 million in grant funding to advance its clinical trials and secure marketing authorization for its therapies. ATXA's innovative approach involves targeting human thromboxane receptors to enhance vasodilation and reduce vasoconstriction, addressing significant unmet medical needs in PAH and other cardiovascular conditions. The team comprises experts in various fields, including cardiovascular and cancer biology, drug discovery, and preclinical pharmacokinetics, positioning ATXA to develop more effective treatments than current standard care options. The company aims to improve treatment outcomes for patients suffering from PAH and related conditions through its advanced therapies.
Tilkal is a Paris-based company founded in 2017 that specializes in developing a software platform for traceability across supply chains. Its end-to-end, real-time traceability solution integrates permissioned blockchain networks with big data to facilitate secure and verifiable data sharing among various supply chain stakeholders. The platform allows businesses to record traceability data of physical products in a ledger, enhancing compliance, transparency, and consumer trust. Tilkal's technology is actively utilized by major corporations such as Groupe Casino and Danone, providing them with the tools to analyze traceability data, manage sourcing risks, and demonstrate environmental, social, and governance (ESG) commitments. By focusing on resilience, sustainability, and ethical practices, Tilkal aims to improve the overall integrity of supply chains across diverse industries.
Beeodiversity is a company with a societal positif impact. Beeodiversity assists companies and local authorities to set up strategies and develop environmental projects generating added value for the environment, the partner and its stakeholders. It combines a scientific expertise, innovative tools based on nature and environmental coaching techniques.
Developer of an optical testing product intended for postoperative monitoring and treatment. The company's product makes the postoperative management of dislocated intraocular lenses intuitive and straightforward, enabling patients to reduce post-operative refractive issues after cataract surgery.
The Weed Whacker from Odd.Bot can be utilized via its Robot-as-a-Service offering and can be hired to clean any field of 10+ hectare. The intelligent robot -or robots- can detect both the weeds and crops already in an early stage and autonomously remove the weeds mechanically, specifically in the crop rows and in between the crops. Its biggest differentiators: sustainability: an alternative for (potential) harmful chemicals versatility: the spacing between the crops may vary resilience: it is highly adaptive and lightweight, which reduces soil compaction
ELEM Biotech
Grant in 2022
ELEM is a start-up company conceived at the Barcelona Supercomputing Center (BSC) and host of MareNostrum supercomputer. ELEM is co-founded by BSC researchers Mariano Vázquez, Guillaume Houzeaux, José María Cela, and business consultant Chris Morton. The company has developed Alya Red, a set of simulation tools, which following a “Software-as-a-Service” model deployed in the cloud, focuses on medical devices and pharmaceutical industries. Alya Red simulates cardiovascular or respiratory systems on “virtual patients”. Combining high performance computing, computational biomechanics and data analysis, these computational avatars can be used by biomedical sector companies and clinicians to elaborate diagnoses, plan treatments, improve drug delivery and action, optimise medical devices, etc. ELEM headquarters are in Barcelona.
Releaf Paper is a producer of sustainable paper products from fallen leaves. They work on the task of finding a solution to achieve sustainability in the production of paper using new raw materials - fallen leaves, instead of wood.
Developer of autonomous greenhouse food production and indoor agriculture robots designed to automate tasks for food production in greenhouse horticulture sector industries. The company specializes in developing harvest and crop-handling robots and artificial intelligence-robotic harvester systems for indoor farming and eliminating factors like climate change and food security pressure, enabling farmers with a controlled climate and protection from the changes outside to get better yields with less land usage.
xFarm S.R.L. is an Italian startup established in 2017, focusing on the digitalization of agriculture. Based in Alessandria, the company designs and develops a comprehensive software-as-a-service platform tailored for farmers and stakeholders in the agrifood industry, including agronomists, dealers, cooperatives, and insurance providers. xFarm's offerings include a user-friendly agricultural application available on mobile and desktop, advanced premium modules, and an analytics dashboard for professionals. The platform is enhanced by a range of Internet of Things (IoT) sensors that are optimized and connected to support effective farm management. By providing innovative tools that address the complexities of modern agriculture, xFarm aims to simplify processes and improve operational efficiency in the agricultural sector.
Tozero, founded in July 2022 in Munich, Germany, by Sarah Fleischer and Dr. Ksenija Milicevic Neumann, focuses on developing technology for recycling lithium-ion batteries. The company aims to create a scalable machine that recovers essential materials such as lithium, nickel, cobalt, graphite, and manganese in an environmentally sustainable manner. By facilitating the recovery of these critical materials, Tozero enables industries to reintegrate fresh raw materials back into the supply chain, thereby supporting broader decarbonization efforts.
Selio is a simple, effective and patent protected technology. The Selio prototype has been rigorously tested in the lab and in subsequent acute pre-clinical in vivo studies with very positive results.
Qu & Co is a developer of quantum-computational software focused on creating algorithms tailored for optimizing specialty chemicals, pharmaceuticals, and functional materials. The company's team of highly skilled quantum developers collaborates closely with clients and academic advisors to design innovative quantum algorithms and translate them into effective software solutions. Qu & Co's offerings enhance in-house discovery and optimization processes by advancing quantum-computational chemistry methods, seamlessly integrating with existing workflows in chemistry and material science. This enables clients in the pharmaceutical and other industries to conduct complex chemistry and multiphysics simulations on emerging quantum processors.
AMT Medical BV has developed a minimal invasive medical device for heart bypass surgery. The AMT Heart Bypass System is based on the ELANA bypass, technology invented by neurosurgeon Prof. Dr. C.A.F. Tulleken and his research team of the UMCU. The technique is designed to make the traditional heart bypass procedures faster, safer, easier and less invasive for the patient.The product has been fully developed, production process has been designed, all pre-clinical trials have finished, a clinical multi-center trial will commence late 2019, early 2020.
Ganymed Robotics SAS, a medical device company, focuses on the development of robotics technologies for orthopedic surgeons. It develops a therapeutic device to enhance surgical precision in knee replacement surgery. The company was incorporated in 2018 and is based in Paris, France.
Resortecs – REcycling, SORting, TEChnologieS – is an award-winning start-up that develops Design for Disassembly solutions. We drive full circularity in the fashion industry with heat-dissolvable stitching threads and thermal disassembly systems that make industrial-scale textile recycling easy. Through targeted innovations in the way clothes are assembled and disassembled, our solutions empower fashion and workwear brands to rise to today’s environmental challenges at the pace and scale Earth needs. All without compromising the creativity, design, and quality of clothing. Resortecs' globally patented thermal disassembly solution is 5X faster than traditional disassembly methods and makes it possible to recycle up to 90% of the original fabric material: • Smart Stitich™, our heat-dissolvable stitching thread with different melting points (150 °C, 170 °C and 190 °C), enables brands to transform their products into recyclable, circular pieces from the manufacturing stage. • Smart Disassembly™, our thermal disassembly system, enables recyclers to unlock higher volumes of premium-quality material, processing up to 4M garments/year with low emissions and no material damage, so that fabrics can be used over and over again. Welcome to sustainability's next level: circularity.
Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry & rodent research technologies to GMP standards and in avian transgenics.
Onward is developing an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools to rehabilitate patients suffering from neurological disorders such as spinal cord injury (SCI).
Tucuvi Care, S.L. is a Madrid-based company that specializes in developing artificial intelligence and voice technology solutions for the healthcare sector. Founded in 2019, Tucuvi's platform serves a variety of clients, including hospitals, insurance companies, telecare services, and patient associations. The company offers an intelligent virtual caregiver designed to support older adults in maintaining their independence at home. Its technology provides personalized care through features such as medication reminders, treatment guidelines, cognitive stimulation exercises, and assessments of caregiver satisfaction. Additionally, Tucuvi's platform aids healthcare professionals by enhancing their ability to monitor and care for patients, particularly those with chronic conditions like heart failure.
Quandela SAS, founded in 2017 and based in Palaiseau, France, specializes in the production of photonic and semiconductor chips designed for quantum computing applications. The company is recognized for its innovative product, E-delight, which serves as a solid-state source of single and highly indistinguishable photons. This technology plays a crucial role in advancing quantum photonics and quantum information research. Quandela's single-photon source device integrates photonics with semiconductor quantum dots, facilitating efficient collection of emitted single photons at high rates. This capability significantly reduces charge noise decoherence and enhances the emission of identical photons, which is vital for the development of advanced quantum technologies, including communication, computation, and sensing. By focusing on the unique properties of quantum light, Quandela contributes to the progress of photon-based quantum computing and communication networks.
Xelera's software makes state-of-the-art accelerator technology accessible to commercial applications in the data center and in the cloud. Due to the growing data volume and emerging demand for real-time analytics, businesses are increasingly required to build up accelerated data processing capabilities. FPGAs and GPUs will become an integral part of tomorrow’s data centers, cloud services and IoT infrastructure, powering a broad range of constantly evolving business applications. Accelerator technology can provide orders-of-magnitude acceleration to business-critical applications using Big Data analytics, machine learning, database management and to IoT infrastructures. FPGAs boost the energy efficiency of data center servers and can substantially reduce TCO.
xFarm S.R.L. is an Italian startup established in 2017, focusing on the digitalization of agriculture. Based in Alessandria, the company designs and develops a comprehensive software-as-a-service platform tailored for farmers and stakeholders in the agrifood industry, including agronomists, dealers, cooperatives, and insurance providers. xFarm's offerings include a user-friendly agricultural application available on mobile and desktop, advanced premium modules, and an analytics dashboard for professionals. The platform is enhanced by a range of Internet of Things (IoT) sensors that are optimized and connected to support effective farm management. By providing innovative tools that address the complexities of modern agriculture, xFarm aims to simplify processes and improve operational efficiency in the agricultural sector.
Reactive Robotics GmbH, founded in April 2015 in Munich, Germany, specializes in the design, manufacture, and sale of rehabilitation robots aimed at facilitating early movement rehabilitation following neurological injuries and orthopedic surgeries. The company's robots are specifically tailored for gait rehabilitation in neurological patients and for use in orthopedic patients recovering from joint replacement procedures. With a team that brings over a decade of experience in rehabilitation robotics and extensive startup knowledge, Reactive Robotics has established a robust clinical network to advance its innovations. The company benefits from a diverse group of advisors who offer guidance in engineering, legal matters, and the regulatory processes necessary for medical device registration, ensuring a comprehensive approach to its operations.
Aviwell is focused on creating healthy, natural, and sustainable solutions aimed at enhancing animal health and growth, thereby contributing to global nourishment. The company operates a microbiota-based discovery platform that leverages artificial intelligence and machine learning to bridge digital and life sciences. By developing innovative food products, Aviwell seeks to provide valuable insights into animal health, growth, and performance, ultimately supporting the agri-food industry in its efforts to sustainably meet the needs of a growing population.
Limula Biotech is a Swiss company specializing in the design and development of an automated system for manufacturing cell and gene therapies. The company has created a patented platform that enables the distributed production of genetically engineered cells directly at the patient's bedside, utilizing a patient's white blood cell sample. This fully closed bioreactor system minimizes human intervention during the manufacturing process while maintaining control over cell culture parameters. By facilitating on-site production in hospitals, Limula's technology aims to enhance the safety, accessibility, and efficiency of personalized gene therapies, ultimately reducing time, costs, and logistical challenges. Founded in 2018 and based in Lausanne, Switzerland, Limula Biotech is committed to revolutionizing the delivery of ex vivo gene-engineered cell therapies.
Orixha has developped an innovative device for cooling patients within few minutes and thus improve their prognosis by using a dedicated liquid ventilator able to perform safe and efficient total liquid ventilation. This method consists in filling the lungs with liquid perfluorocarbons and due to the high gases solubility and the large pulmonary sufaces can use the lungs as heat exchanger.
Quanturi Oy, founded in 2016 and based in Espoo, Finland, specializes in the development and provision of continuous monitoring solutions for fermentable products, catering to the agricultural, forestry, and waste sectors. The company offers a range of wireless monitoring systems, including those for compost temperature, grain management, and hay monitoring, ensuring the safety and quality of stored materials. Its platform provides real-time alerts for potential hazards, enhancing traceability and reducing handling costs. By enabling farmers and industry professionals to monitor their products effectively, Quanturi aims to prevent business disruptions and mitigate risks associated with spoilage or accidents. The company has expanded its presence across various countries, including France, Great Britain, the Netherlands, Switzerland, Italy, and Belgium, and sells its products online to reach a broader market.
Qarnot is a company based in Montrouge, France, founded in 2010, that specializes in providing economical and ecological high-performance computing (HPC) solutions through its innovative Q.rad computing heater. This unique product combines the functionality of an electrical heater with high-performance computing capabilities, utilizing embedded microprocessors to generate heat during computation. Qarnot's computing heaters have undergone three generations of development and are marketed to construction companies for use in new buildings. By integrating computing and heating, Qarnot offers an affordable alternative to traditional data centers, significantly reducing costs associated with infrastructure, maintenance, and cooling. Users can conveniently manage the temperature of these heaters through an embedded thermostat or a smartphone application, enhancing the overall user experience.
Methinks Software, founded in 2016 and based in Barcelona, Spain, specializes in developing artificial intelligence medical software focused on stroke diagnosis and treatment. Utilizing advanced techniques from Google's deep learning framework, TensorFlow, the company analyzes neuroimaging to provide timely and accurate diagnoses of brain-related diseases, particularly acute strokes. Its medical imaging platform enables rapid assessment from non-contrast CT scans, streamlining the diagnosis process and facilitating improved communication between radiologists, hospitals, stroke units, and healthcare professionals. By bypassing the need for contrast CT scans, Methinks aims to reduce time-to-treatment, ultimately enhancing clinical outcomes and patient care in emergency settings.
Quandela SAS, founded in 2017 and based in Palaiseau, France, specializes in the production of photonic and semiconductor chips designed for quantum computing applications. The company is recognized for its innovative product, E-delight, which serves as a solid-state source of single and highly indistinguishable photons. This technology plays a crucial role in advancing quantum photonics and quantum information research. Quandela's single-photon source device integrates photonics with semiconductor quantum dots, facilitating efficient collection of emitted single photons at high rates. This capability significantly reduces charge noise decoherence and enhances the emission of identical photons, which is vital for the development of advanced quantum technologies, including communication, computation, and sensing. By focusing on the unique properties of quantum light, Quandela contributes to the progress of photon-based quantum computing and communication networks.
Synergia Medical SA, founded in 2013 and based in Mont-Saint-Guibert, Belgium, specializes in the development of innovative neurostimulation medical devices. The company is focused on creating optoelectronic neurostimulators that utilize advanced materials, optical components, biosensors, and microelectronics. In particular, Synergia Medical aims to manufacture MRI-safe, implanted devices designed for treating drug-resistant epilepsy, with potential applications in other therapeutic areas. The company has achieved ISO13485 certification within a short period and has successfully developed and marketed an OEM external neurostimulator for motorized amputee prostheses. Supported by private investors and public research grants, Synergia Medical has rapidly expanded its team to include thirteen skilled professionals dedicated to advancing neurostimulation technology.
Qubit Pharmaceuticals, incorporated in 2020 and based in Paris, France, develops innovative technology aimed at enhancing pharmaceutical drug discovery. The company offers a drug discovery simulation platform that reduces the cost and duration of preclinical drug development. Utilizing proprietary force field models and molecular dynamics calculations, Qubit's platform conducts virtual screening and visualization to identify promising drug candidates. This approach leverages quantum physics to support biopharmaceutical companies in accelerating their research and development efforts.
ATRO Medical B.V., based in Nijmegen, the Netherlands, specializes in the development of an anatomically shaped polymer-based meniscus implant known as the Trammpolin. This innovative implant is designed to restore the protective function of the meniscus by acting as a spacer in the joint. ATRO Medical emerged as a spin-out from DSM and Radboudumc, leveraging expertise gained from a collaborative initiative that began in 2010, which included universities, private companies, and support from the Dutch government. The company combines clinical, biomechanical, and polymer knowledge to advance the Trammpolin design and its prototype development.
Loci Orthopaedics Limited is a medical technology company based in Upper Newcastle, Ireland, focused on developing innovative solutions for orthopedic care. Established in 2017, the company specializes in the InDx implant, which is designed to treat arthritis in the thumb base joint. This implant uniquely mimics the natural motions of the thumb joint, providing a less invasive and easier insertion method compared to existing surgical options. Loci Orthopaedics also emphasizes evidence-based designs in its products, aiming to address significant unmet clinical needs in orthopedic extremities.
QuantWare engages in designing, developing, and fabricating hardware to enable quantum computing.
Loci Orthopaedics Limited is a medical technology company based in Upper Newcastle, Ireland, focused on developing innovative solutions for orthopedic care. Established in 2017, the company specializes in the InDx implant, which is designed to treat arthritis in the thumb base joint. This implant uniquely mimics the natural motions of the thumb joint, providing a less invasive and easier insertion method compared to existing surgical options. Loci Orthopaedics also emphasizes evidence-based designs in its products, aiming to address significant unmet clinical needs in orthopedic extremities.
Hy2Care BV is a business start-up of the University of Twente, the Netherlands. It is Hy2Care’s ambition to introduce into the market the first cure for Osteoarthritis, the injectable hydrogel.
Osteoarthritis is the 4th leading cause of mobility associated disability and affects more than 100 million patients in the Western world, who are all in need for an effective treatment.
It is the aim of Hy2Care to change the future for patients suffering from osteoarthritis.
Nuventura GmbH, founded in 2017 and based in Berlin, Germany, specializes in the design and development of gas-insulated switchgear (GIS) technology. The company focuses on creating innovative switchgear solutions that replace sulfur hexafluoride (SF6) with dry air, significantly reducing the use of greenhouse gases in the energy supply sector. Nuventura's technology maintains the benefits of traditional SF6 switchgear while adhering to existing IEC standards, allowing industries to effectively control, protect, and isolate electrical equipment. This approach facilitates improved monitoring of switchgear health and addresses environmental concerns associated with greenhouse gas emissions.
Avantama is a leading developer of nanomaterials specifically tailored for electronic applications. The company specializes in nanoparticle dispersions and formulations, offering a range of services including joint development, contract licensing, and customized compositions. Avantama's innovative material technologies facilitate the creation of high-quality optical and electronic coatings using established printing and coating techniques. With a production capacity at the multi-ton scale and adherence to high industry standards, Avantama supports various applications such as displays, OLEDs, Quantum Dot Displays, and solution-processed organic photovoltaics. This capability not only enhances product development but also accelerates time-to-market for its clients, positioning Avantama as a preferred partner for future innovations in the electronics sector.
Piomic is a developer of a portable, hand-held medical device designed to treat chronic wounds, specifically targeting chronic leg and foot ulcers. The device utilizes optical and magnetic stimulation technologies to promote wound healing, aiming to alleviate the significant burden posed by the estimated 50 million patients suffering from hard-to-heal wounds globally. Clinical studies have demonstrated that the treatment is safe, accelerates wound closure, reduces pain, and enhances the overall quality of life for patients. The device features a simple, single-button operation, allowing for seamless integration into various healthcare settings, including stationary facilities, ambulatory care, and home use. Through its innovative approach, Piomic seeks to improve patient outcomes and provide a more effective solution for managing chronic wounds.
Miraex SA, established in 2019 and headquartered in Lausanne, Switzerland, specializes in the development and manufacturing of photonic and quantum solutions. The company focuses on creating advanced photonic sensors, quantum transducers, and quantum converters aimed at enhancing industrial applications, aerospace security, and defense, as well as quantum networking and computing. Miraex's innovative systems are designed to operate in challenging environments where traditional electronic sensors are ineffective, allowing for proactive asset failure prevention. Additionally, the company constructs quantum integrated circuits tailored for high-sensitivity measurements and supports the infrastructure necessary for distributed quantum computing.
Lumiphase develops novel optical communication chips that are very inexpensive, super compact, and highly efficient.
Gr3n invented a new process which allows for the first time to recycle PET bottles/food containers chemically in a profitable way. Gr3n developed an innovative process, based on a new application of microwave technology to a well known chemical reaction which provides for the first time with an economically efficient chemical recycling process of PET (Polyethylene Terephtalate) and allows an industrial implementation of this recycling method. This new process can potentially change how PET is recycled worldwide with a huge financial benefit for the recycling industry.
Oxara AG, founded in 2018 and based in Zurich, Switzerland, specializes in sustainable building products aimed at addressing challenges in the construction industry. The company focuses on the circular economy by utilizing locally available landfill waste, such as excavation materials, to produce a unique poured earth concrete. This innovative material retains the advantages of traditional concrete while being significantly cheaper and 90% more environmentally friendly. Oxara offers a range of products, including additives and branded materials like Oxacrete, Oxaflow, Oxabrick, Cleancrete, Cleanflow, and Cleanbrick. The company is committed to fostering a global community dedicated to sustainable construction and affordable housing solutions, prioritizing the needs of its employees and clients.
Nuclidium’s vision is to address the unmet need to detect and stage cancer more accurately so that treatment options for cancer patients and their long-term survival can be significantly improved.
KOVE is a medical device company.
Plair SA develops and manufactures systems for preventive environment monitoring. It offers Rapid-E, an instrument that accurately and comprehensively analyze single aerosol particles in real time; and Rapid-C uses laser-induced fluorescence and light scattering detection, providing unprecedented high-level output in particle counts. The company was founded in 2014 and is based in Plan-les-Ouates, Switzerland.
Dimpora AG, based in Zürich, Switzerland, specializes in the design and manufacture of eco-friendly waterproof membranes for the outdoor textile industry. The company produces functional membranes that are primarily composed of polyurethane and utilize a unique template removal method to achieve breathability while maintaining water resistance. Dimpora's innovative technology allows for the direct application of membranes onto various 3D surfaces, enabling fast sweat transport and complete protection from rain. Committed to sustainability, Dimpora aims to develop next-generation high-performance membranes that enhance outdoor experiences without compromising environmental integrity. The company focuses on creating products that not only perform well but also prioritize the use of recyclable materials, aligning with its vision of promoting responsible enjoyment of nature.
embotech AG specializes in developing decision-making software solutions for autonomous systems. Founded in 2013 as a spin-off from the Automatic Control Laboratory at ETH Zurich, the company provides FORCES Pro, a numerical optimization software that enables the design of complex control systems. This software is utilized in various applications, including the control of wind turbines, planning the collision-free motion of autonomous drones, and the development of advanced driver assistance systems. Additionally, it supports precision landing of spacecraft on other planets and the recovery of reusable rockets. Embotech's solutions cater to sectors such as automotive, energy, and robotics, aiming to enhance safety, productivity, and energy efficiency in automated decision-making processes. The company is headquartered in Zurich, Switzerland.
Artiria Medical SA develops micro-actuated device to treat vascular diseases. Its products bring micromotion deep in the brain arteries, enabling a navigation and stroke treatment. It empowers catheters and guidewires. Artiria Medical SA was incorporated in 2019 and is based in Lausanne, Switzerland.
Neurosoft Bioelectronics specializes in the development of soft implantable electrodes designed to interface with the nervous system for diagnosing and treating neurological disorders. Based in Geneva, Switzerland, the company has created next-generation electrodes that are compliant and conformable, addressing the limitations of existing stiff devices. Their flagship product, SOFT ECoG, is a subdural electrode that records from and stimulates the brain's surface, enhancing recording quality and minimizing MRI artifacts. Neurosoft's technology promotes long-term bio-integration, adapting to both static and dynamic mechanics of neural tissue, which can improve therapeutic outcomes for patients and expand the applications of neural interfaces in clinical settings.
DePoly is a spin off out of the LSMO lab at EPFL- Valais that has developed a novel technology allowing for the chemical recycling of PET plastic back to its main two components ethylene glycol (EG) and terephthalic acid (TPA). Our approach turns low valued materials (PET waste) into high-valued chemicals like TPA creating a circular economy. We expect this process to generate revenue from chemically recycling PET to TPA/EG, which can be sold back to industry to make new virgin PET plastic and allowing for a sustainable source of TPA and EG on the market.
Legacy Healthcare is a biopharma company focused on the development of oncology supportive care and dermatology drugs
Swiss Airtainer has developed a temperature-controlled container for the transport of pharmaceutical products by air.
OxyPrem AG is a Swiss company that develops, designs, and manufactures advanced sensor solutions specifically for monitoring preterm infants. Founded in 2018 and based in Zurich, it offers a reusable oxygen sensor that continuously measures hemoglobin oxygen saturation in any human tissue, particularly focusing on the brains of high-risk preterm infants. By employing noninvasive near-infrared light technology, the device provides real-time monitoring, enabling healthcare professionals to prevent severe outcomes such as early death or long-term brain damage in this vulnerable population. OxyPrem's innovative approach not only enhances clinical care but also significantly reduces medical waste associated with single-use devices.
Dracula Technologies SAS specializes in the design and manufacture of organic photovoltaic cells aimed at providing energy autonomy for connected devices. Founded in 2011 and based in Valence, France, the company develops products that enable small electronic devices, such as phones, GPS units, and lamps, to self-recharge using solar energy. Their flagship product, Light As Your Energetic Response (LAYER), is designed to capture various forms of light, both indoors and outdoors, and convert it into usable energy through advanced digital printing techniques. The team consists of approximately 20 members, including a scientific committee and an administrative committee, all dedicated to fostering innovation and collaboration within the company. Dracula Technologies operates as a subsidiary of Ardeje.
Venari Medical Limited, founded in 2018 and based in Galway, Ireland, develops innovative medical devices aimed at treating chronic venous diseases (CVD). The company's flagship product, BioVena, employs the body's natural healing processes to provide a more effective and less invasive treatment option for conditions such as varicose veins and venous ulcers. Venari Medical seeks to address the significant gap in treatment, as only a small fraction of the 120 million individuals suffering from venous disease in the US and EU receive adequate care. Their technology not only offers a safer alternative to existing methods but also targets the underserved population of venous ulcer patients who currently rely on ineffective compression bandaging. By widening the indications for superficial venous ablation, Venari Medical aims to reduce the annual costs associated with venous ulcers, which total approximately $33 billion for insurers in these regions. The company's commitment to patient-centered solutions positions it to disrupt traditional treatment practices that have seen limited innovation in recent years.
Ignion is an antenna innovator that creates a multiband, multipurpose and ready-to-use antenna. The company was founded in 2015 and is based in Sant Cugat del Vallès, Spain.
Connecting Food is a foodtech company based in Paris, France, that specializes in a blockchain-based platform for real-time tracking and auditing of food products. Established in 2016, the company offers LiveAudit, an application that allows digital auditing of product quality throughout the entire production process. This platform enables consumers, particularly those purchasing eggs, to access detailed information about the hen's breed, the farm of origin, and the packing location. By leveraging blockchain technology, Connecting Food provides a transparent supply chain solution that fosters trust among farmers, manufacturers, retailers, and consumers, thereby enhancing brand equity and ensuring the integrity of agricultural and finished products.
Perha Pharmaceuticals is a biotechnology company dedicated to the research and development of innovative therapies aimed at addressing hearing loss and cognitive disorders. The company focuses on preventing cisplatin-induced hearing loss and developing treatments for cognitive conditions related to Down syndrome and Alzheimer's disease. Perha Pharmaceuticals leverages natural marine substances in its research, with chemists and biologists optimizing molecules derived from marine organisms to create effective kinase inhibitors. This approach underscores the company's commitment to advancing medical treatments and improving patient care in areas of significant unmet need.
Ignion is an antenna innovator that creates a multiband, multipurpose and ready-to-use antenna. The company was founded in 2015 and is based in Sant Cugat del Vallès, Spain.
XenomatiX develops automotive Lidar solutions.
Scipio Bioscience is a biotechnology company based in Paris, France, founded in 2017. The company specializes in manufacturing benchtop kits that serve as a sample preparation solution for single-cell studies. These kits are designed for use in sequencing applications within both clinical and basic research, focusing particularly on transcriptomics. By enabling single-cell barcoding in a test tube format, Scipio Bioscience's products facilitate advanced research in single-cell analysis, supporting laboratories in their scientific endeavors.
Saalg Geomechanics is owner and operator of an engineering company intended to offer specialized advanced geological and numerical services. The company offers numerical model calibrations and soil and rock parameters characterization by backanalysis and inverse analysis, 2D and 3D geomechanical and geotechnical simulations, manily for TBM Tunnel Excavations, Conventional Tunnels, Large and deep excavations, reinforced earth retaining walls and wellbore stabity analysis, enabling their customers to build a bridge between academic research in the field of geomechanics and the industry.
Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.
Core Biogenesis is a biotechnology company building next-generation recombinant protein production technologies. The company uses proprietary gene editing and plant biotechnology to drastically reduce the cost of making growth factors. The growth factors are molecules used in the clean meat and cell therapy industries.
PrediSurge is a software company that offers design and support solutions for physicians and medical device companies.
AdjuCor is a high-tech medical device company that owns and is responsible for development, production, marketing and selling of a revolutionary technology for the treatment of end-stage heart failure patients. Its flagship product is called BEAT. The market introduction of BEAT will be the world’s first commercially available, minimal invasive application of mechanical circulatory support for the failing heart. It provides uni- or biventricular support, while also completely avoiding contact with blood. This unique feature set will allow for the transformation of standard-of-care treatment in end-stage heart failure, as well as greatly expand treatment to previously unreached patients.
New Born Solutions is a medical device company that provides non-invasive screening for infant meningitis.
Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry & rodent research technologies to GMP standards and in avian transgenics.
Nuventura GmbH, founded in 2017 and based in Berlin, Germany, specializes in the design and development of gas-insulated switchgear (GIS) technology. The company focuses on creating innovative switchgear solutions that replace sulfur hexafluoride (SF6) with dry air, significantly reducing the use of greenhouse gases in the energy supply sector. Nuventura's technology maintains the benefits of traditional SF6 switchgear while adhering to existing IEC standards, allowing industries to effectively control, protect, and isolate electrical equipment. This approach facilitates improved monitoring of switchgear health and addresses environmental concerns associated with greenhouse gas emissions.
Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.
PeekMed is a 3D pre-operative planning system for orthopedic surgery that aims to help the surgeon better treat the patient while reducing costs. With PeekMed the surgeon can plan: - Total Joint Replacements; - Osteotomies; - Fracture reductions; - Virtually any orthopedic procedure. The output of PeekMed system can later be used as an input for: - Navigation systems; - 3D printers; - Robotics; - Mobile devices. PeekMed was founded by Jaime Campos, Sara Silva, and João Pedro Ribeiro in 2015 and is located in Braga, Portugal.
Novolyze, SAS is a French company that specializes in food safety solutions for the global food processing industry. Established in 2012 and headquartered in Daix, with an additional office in Cambridge, Massachusetts, Novolyze provides a comprehensive range of equipment, including steam pasteurizers, sterilizers, dryers, roasters, extruders, and ovens. The company is also known for its innovative surrogate microorganisms technology, which allows food manufacturers to test the effectiveness of microbial kill steps under real-life conditions. In addition to its equipment offerings, Novolyze provides services in pasteurization, regulatory compliance, and process validation, as well as food microbiology research to a diverse clientele that includes large corporations, small and medium enterprises, public and private research laboratories, and food processing associations. With a strong emphasis on enhancing food safety and quality, Novolyze employs a team of experts, including food microbiologists and process engineers, and operates state-of-the-art facilities in a pharmaceutical-grade environment for research and development.
New Born Solutions is a medical device company that provides non-invasive screening for infant meningitis.
Nagi Bioscience SA, based in Lausanne, Switzerland, specializes in the development and manufacturing of an innovative automated testing device that utilizes Caenorhabditis elegans, a type of microscopic worm, for the assessment of substances in pharmaceutical, chemical, and cosmetic industries. This technology, known as "Organism-on-Chip," integrates in vivo testing with a fully automated in vitro platform for handling, culturing, and analyzing these organisms. Nagi Bioscience's solutions facilitate toxicity testing, drug discovery, and anthelmintic testing, allowing clients to gain insights into the complete biological responses that can only be observed at the organism level. This approach aims to transform traditional methods of evaluating the toxic or beneficial effects of various substances.
Deasyl is identified, in-licence, and develops novel chemistry into scalable processes used by major fine chemical and petrochemical players.
Qnami AG manufactures non-invasive sensors. Its products include ProteusQ, non-invasive magnetic imaging microscope; and Quantum Diamond, which includes Quantilevers MX, diamond probes containing a single NV for high resolution magnetic imaging, and NV diamond membranes, ready-to-use diamond with NV centers. Its applications are multiferroic antiferromagnet, antiferromagnetic ram, microwave imaging, magnetic nanomemories, and superconductivity. Qnami AG was founded in 2017 and is based in Basel, Switzerland.
Insolight is an energy company that develops and manufactures solar panels.
Insolight has developed solar modules with record efficiency 29 percent to reduce residential solar electricity costs below 0.1 $/kWh. Its innovative optical technology combines high efficiency with the ease of mounting of a standard flat panel. Insolight has successfully passed third-party validation at Fraunhofer ISE (36% efficiency on Lab prototype) and at the UPM in Madrid (29% on pre-industrial module). Its business model is to develop the IP, control wholesale distribution and outsource manufacturing.
The company was founded in 2015.
Bloom Biorenewables Ltd is a company focused on developing innovative technology to convert wood and agricultural waste into renewable materials that can replace petroleum-based products. Incorporated in 2019 and based in Marly, Switzerland, the company aims to provide sustainable alternatives for various industries, including chemicals, fragrances, plastics, and textiles. By employing a biomass deconstruction technology platform, Bloom Biorenewables offers a cost-effective method to extract bio-based molecules from plant materials. This approach not only helps customers reduce their reliance on fossil fuels but also contributes to efforts in mitigating climate change by lowering carbon footprints and supporting the transition to a circular economy.
Scrona is all about simplifying micro- and nanotechnology, from the consumer- and industry-perspective. We offer solutions for convenient microscopic visualization and develop an ink-jet related printing technology that will revolutionize micro- and nanofabrication.
Headmade Materials GmbH, founded in 2019 and based in Würzburg, Germany, specializes in developing materials and processes for metal 3D printing, specifically through its Cold Metal Fusion technology. The company focuses on the production of serial metal parts, offering services that include part design, small-scale series production, and process consulting. By providing standard and customized feedstocks, Headmade Materials aims to enhance component output and streamline post-processing. Their expertise supports additive-compatible design and reliable production processes, enabling clients to manufacture advanced printed metal parts in a cost-effective manner.
Headmade Materials GmbH, founded in 2019 and based in Würzburg, Germany, specializes in developing materials and processes for metal 3D printing, specifically through its Cold Metal Fusion technology. The company focuses on the production of serial metal parts, offering services that include part design, small-scale series production, and process consulting. By providing standard and customized feedstocks, Headmade Materials aims to enhance component output and streamline post-processing. Their expertise supports additive-compatible design and reliable production processes, enabling clients to manufacture advanced printed metal parts in a cost-effective manner.
DyeMansion GmbH, founded in 2013 and based in Munich, Germany, specializes in the post-processing and coloring of 3D-printed laser sintered parts. The company provides high-volume finishing systems that streamline the transition from raw 3D-printed components to high-value consumer and industrial products. With a focus on precision coloring and finishing, DyeMansion serves over four hundred clients, including prominent global manufacturers across various sectors such as eyewear, automotive, retail, medical, and sports equipment. The company has established itself as a leader in additive manufacturing finishing systems for polymer parts, collaborating with major industrial 3D printing systems like EOS, HP, 3D Systems, and Prodways. DyeMansion's technology enables the production of items ranging from luxury sunglasses to essential automotive components, ensuring high-quality results tailored to customer specifications.
Spartha Medical is a medical technology company focused on developing eco-friendly, invisible coatings designed for medical devices and consumer products to mitigate microbial and inflammatory risks. Utilizing natural biopolymers, the company’s innovative coatings possess antibacterial, antiviral, and anti-inflammatory properties, providing an effective solution for infection control. The technology relies on a patented method of supramolecular assembly, enabling precise control over the properties of the coatings based on specific applications. This approach allows for the creation of multifunctional and easy-to-apply surface treatments that help healthcare institutions maintain disease-free environments on medical devices.
Patchstack, formerly known as WebARX, operates a comprehensive website security and monitoring platform designed to protect businesses from website vandalism and cyber threats. Founded in 2017 and headquartered in Pärnu, Estonia, Patchstack offers a suite of services including website monitoring, malware removal, and a web application firewall. The platform consolidates various security features, such as uptime monitoring and domain reputation checks, into a single, user-friendly dashboard, making it accessible even to small website owners. Patchstack analyzes approximately 3,000 hacking incidents daily, leveraging its private threat intelligence to enhance protection against vulnerabilities and security breaches. Through its services, Patchstack aims to safeguard websites from emerging cyber risks and ensure their integrity.
Amadix is focused on developing and commercializing innovative cancer diagnostic technologies that address unmet medical needs in oncology. The company's flagship product, Colofast, is a non-invasive screening signature for colorectal cancer and advanced adenoma diagnosis, aimed at reducing the high mortality rate associated with colon cancer. Amadix's approach emphasizes early detection, allowing for timely treatment while avoiding the complications of invasive procedures like tumor biopsies. The team comprises industry veterans with extensive expertise in oncology diagnostics, the pharmaceutical industry, and biotechnology, supported by independent board members who provide strategic guidance in commercialization and business development, particularly in Europe and the United States. Amadix's products undergo rigorous analytical validation and clinical studies before being introduced to the global market.
Smartlane GmbH, founded in 2015 and based in Munich, Germany, specializes in developing SmartlaneDISPATCH!, a mobile application for efficient order and tour management. This cloud-based software enhances delivery services by automating scheduling, tour planning, and route optimization. Users can easily monitor deliveries, drivers, and tours, while also adding new customer addresses on a map. The application facilitates real-time communication by notifying customers about arrival times through SMS, WhatsApp, or email. Smartlane serves a diverse clientele, including delivery and courier services, care and disposal providers, field service technicians, and passenger transport companies. The platform integrates seamlessly with existing systems via API, making it a comprehensive solution for businesses looking to optimize their vehicle fleet operations.
Xeltis AG is a clinical-stage medical device company based in Zurich, Switzerland, with additional research and development facilities in Eindhoven, the Netherlands. Founded in 2006, Xeltis focuses on developing bio-absorbable heart valves and blood vessels that facilitate the body's natural healing processes. Its innovative technology, known as RestoreX, employs a therapeutic approach called Endogenous Tissue Restoration (ETR), which allows patients' own bodies to generate new heart valves. Through ETR, the porous structure of Xeltis' heart valves, made from bioabsorbable polymers, enables tissue to integrate with the implant, gradually forming a fully functional valve while the device itself is absorbed by the body. This groundbreaking approach aims to transform the treatment of heart valve disease by restoring natural heart valve function.
Xeltis AG is a clinical-stage medical device company based in Zurich, Switzerland, with additional research and development facilities in Eindhoven, the Netherlands. Founded in 2006, Xeltis focuses on developing bio-absorbable heart valves and blood vessels that facilitate the body's natural healing processes. Its innovative technology, known as RestoreX, employs a therapeutic approach called Endogenous Tissue Restoration (ETR), which allows patients' own bodies to generate new heart valves. Through ETR, the porous structure of Xeltis' heart valves, made from bioabsorbable polymers, enables tissue to integrate with the implant, gradually forming a fully functional valve while the device itself is absorbed by the body. This groundbreaking approach aims to transform the treatment of heart valve disease by restoring natural heart valve function.
Multiverse Computing SL develops software for the finance industry. It develops software for solving financial and macro-economic problems. The company was incorporated in 2019 and is based in San Sebastian, Spain with an additional office in Toronto, Canada.